Cargando…

Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update

Pancreatic neuroendocrine neoplasms (panNENs) are part of a large family of tumors arising from the neuroendocrine system. PanNENs show low–intermediate tumor grade and generally high somatostatin receptor (SSTR) expression. Therefore, panNENs benefit from functional imaging with (68)Ga-somatostatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prosperi, Daniela, Gentiloni Silveri, Guido, Panzuto, Francesco, Faggiano, Antongiulio, Russo, Vincenzo Marcello, Caruso, Damiano, Polici, Michela, Lauri, Chiara, Filice, Angelina, Laghi, Andrea, Signore, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694730/ https://www.ncbi.nlm.nih.gov/pubmed/36431313 http://dx.doi.org/10.3390/jcm11226836

Ejemplares similares

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Foreword to the special issue on advances in neuroendocrine neoplasms
por: Vitale, Giovanni, et al.
Publicado: (2021)

Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function
por: Zamponi, Virginia, et al.
Publicado: (2022)

CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors
por: Caruso, Damiano, et al.
Publicado: (2022)

Management decisions of an Academic Radiology Department during COVID-19 pandemic: the important support of a business analytics software
por: Laghi, Andrea, et al.
Publicado: (2022)

Editorial for Special Issue on Imaging Biomarker in Oncology
por: Polici, Michela, et al.
Publicado: (2023)

Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center
por: Magi, Ludovica, et al.
Publicado: (2019)

Immune cell labelling and tracking: implications for adoptive cell transfer therapies
por: Galli, Filippo, et al.
Publicado: (2021)

Role of [(18)F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors
por: Magi, Ludovica, et al.
Publicado: (2022)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
por: Altieri, Barbara, et al.
Publicado: (2019)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
por: Malandrino, Pasqualino, et al.
Publicado: (2022)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy
por: Signore, Alberto, et al.
Publicado: (2020)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren’s Syndrome by (99m)Tc-Interleukin-2: Diagnostic and Therapeutic Implications
por: Campagna, Giuseppe, et al.
Publicado: (2022)

A Case Report of Multiple Gastrointestinal Stromal Tumors: Imaging Findings, Surgical Approach, and Review of the Literature
por: Tarallo, Mariarita, et al.
Publicado: (2022)

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
por: Dromain, Clarisse, et al.
Publicado: (2021)

How new technologies could impact on radiology diagnosis and assessment of pancreatic lesions: Future perspectives
por: Laghi, Andrea, et al.
Publicado: (2018)

CT based radiomic approach on first line pembrolizumab in lung cancer
por: Zerunian, Marta, et al.
Publicado: (2021)

Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?
por: Rimbaş, Mihai, et al.
Publicado: (2022)

Diagnostic performance of CT lung severity score and quantitative chest CT for stratification of COVID-19 patients
por: Caruso, Damiano, et al.
Publicado: (2022)

Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia: A Case Series
por: Rinzivillo, Maria, et al.
Publicado: (2022)

Chest CT Features of COVID-19 in Rome, Italy
por: Caruso, Damiano, et al.
Publicado: (2020)

Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Imaging of abdominal complications of COVID-19 infection
por: Caruso, Damiano, et al.
Publicado: (2021)

Clinical Challenges in the Management of Neuroendocrine Tumors
por: Panzuto, Francesco
Publicado: (2021)

Neuroendocrine neoplasms of the esophagus and stomach
por: Mastracci, Luca, et al.
Publicado: (2021)

Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients
por: Caruso, Damiano, et al.
Publicado: (2020)

Updates on Quantitative MRI of Diffuse Liver Disease: A Narrative Review
por: Zerunian, Marta, et al.
Publicado: (2022)

Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors
por: Faggiano, Antongiulio, et al.
Publicado: (2023)

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
por: Cavalcanti, Elisabetta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p0drddbk1c12rddqk8jvi605cb